KMPH Annual SG&A
$8.70 M
+$780.00 K+9.85%
31 December 2021
Summary:
As of January 25, 2025, KMPH annual selling, general & administrative expenses is $8.70 million, with the most recent change of +$780.00 thousand (+9.85%) on December 31, 2021. During the last 3 years, it has fallen by -$3.81 million (-30.44%).KMPH Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KMPH Quarterly SG&A
$3.97 M
+$416.00 K+11.69%
30 September 2022
Summary:
As of January 25, 2025, KMPH quarterly selling, general & administrative expenses is $3.97 million, with the most recent change of +$416.00 thousand (+11.69%) on September 30, 2022. Over the past year, it has increased by +$2.03 million (+104.00%).KMPH Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KMPH TTM SG&A
-$1.13 B
-$35.23 M-3.22%
30 September 2022
Summary:
As of January 25, 2025, KMPH TTM selling, general & administrative expenses is -$1.13 billion, with the most recent change of -$35.23 million (-3.22%) on September 30, 2022. Over the past year, it has dropped by -$1.14 billion (-13110.58%).KMPH TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KMPH Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +9.8% | +104.0% | -10000.0% |
| 3 y3 years | -30.4% | +10.0% | -10000.0% |
| 5 y5 years | -31.9% | +19.7% | -10000.0% |
KMPH Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -48.8% | -35.0% | -6733.8% |
KemPharm Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $3.97 M(+11.7%) | $12.82 M(+18.8%) |
| June 2022 | - | $3.56 M(+30.1%) | $10.80 M(+13.1%) |
| Mar 2022 | - | $2.73 M(+7.0%) | $9.54 M(+9.7%) |
| Dec 2021 | $8.70 M(+9.8%) | $2.56 M(+31.2%) | $8.70 M(+0.3%) |
| Sept 2021 | - | $1.95 M(-15.5%) | $8.67 M(+6.4%) |
| June 2021 | - | $2.31 M(+21.8%) | $8.15 M(+7.7%) |
| Mar 2021 | - | $1.89 M(-25.2%) | $7.57 M(-4.5%) |
| Dec 2020 | $7.92 M(-26.8%) | $2.53 M(+76.9%) | $7.92 M(+17.0%) |
| Sept 2020 | - | $1.43 M(-16.9%) | $6.77 M(-24.4%) |
| June 2020 | - | $1.72 M(-23.4%) | $8.95 M(-12.4%) |
| Mar 2020 | - | $2.25 M(+63.2%) | $10.22 M(-5.5%) |
| Dec 2019 | $10.82 M(-13.5%) | $1.38 M(-61.9%) | $10.82 M(-12.8%) |
| Sept 2019 | - | $3.61 M(+20.9%) | $12.40 M(+5.3%) |
| June 2019 | - | $2.99 M(+5.3%) | $11.78 M(-3.5%) |
| Mar 2019 | - | $2.84 M(-4.3%) | $12.21 M(-2.4%) |
| Dec 2018 | $12.51 M | $2.96 M(-0.9%) | $12.51 M(+2.9%) |
| Sept 2018 | - | $2.99 M(-12.5%) | $12.16 M(-2.6%) |
| June 2018 | - | $3.42 M(+9.2%) | $12.48 M(-1.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | $3.13 M(+19.8%) | $12.64 M(-1.0%) |
| Dec 2017 | $12.77 M(-24.9%) | $2.61 M(-21.2%) | $12.77 M(-2.0%) |
| Sept 2017 | - | $3.32 M(-7.1%) | $13.03 M(-17.7%) |
| June 2017 | - | $3.57 M(+9.4%) | $15.83 M(-4.3%) |
| Mar 2017 | - | $3.27 M(+13.7%) | $16.54 M(-2.8%) |
| Dec 2016 | $17.01 M(+91.5%) | $2.87 M(-53.0%) | $17.01 M(+1.8%) |
| Sept 2016 | - | $6.11 M(+42.6%) | $16.70 M(+31.1%) |
| June 2016 | - | $4.29 M(+14.7%) | $12.74 M(+9.4%) |
| Mar 2016 | - | $3.74 M(+45.6%) | $11.64 M(+31.1%) |
| Dec 2015 | $8.88 M(+96.3%) | $2.57 M(+19.2%) | $8.88 M(+12.5%) |
| Sept 2015 | - | $2.15 M(-32.5%) | $7.89 M(+15.6%) |
| June 2015 | - | $3.19 M(+226.3%) | $6.83 M(+37.4%) |
| Mar 2015 | - | $977.00 K(-38.0%) | $4.97 M(+9.8%) |
| Dec 2014 | $4.53 M(+235.0%) | $1.58 M(+45.2%) | $4.53 M(+53.5%) |
| Sept 2014 | - | $1.09 M(-18.3%) | $2.95 M(+58.3%) |
| June 2014 | - | $1.33 M(+149.1%) | $1.86 M(+249.1%) |
| Mar 2014 | - | $534.00 K | $534.00 K |
| Dec 2013 | $1.35 M | - | - |
FAQ
- What is KemPharm annual selling, general & administrative expenses?
- What is the all time high annual SG&A for KemPharm?
- What is KemPharm annual SG&A year-on-year change?
- What is KemPharm quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for KemPharm?
- What is KemPharm quarterly SG&A year-on-year change?
- What is KemPharm TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for KemPharm?
- What is KemPharm TTM SG&A year-on-year change?
What is KemPharm annual selling, general & administrative expenses?
The current annual SG&A of KMPH is $8.70 M
What is the all time high annual SG&A for KemPharm?
KemPharm all-time high annual selling, general & administrative expenses is $17.01 M
What is KemPharm annual SG&A year-on-year change?
Over the past year, KMPH annual selling, general & administrative expenses has changed by +$780.00 K (+9.85%)
What is KemPharm quarterly selling, general & administrative expenses?
The current quarterly SG&A of KMPH is $3.97 M
What is the all time high quarterly SG&A for KemPharm?
KemPharm all-time high quarterly selling, general & administrative expenses is $6.11 M
What is KemPharm quarterly SG&A year-on-year change?
Over the past year, KMPH quarterly selling, general & administrative expenses has changed by +$2.03 M (+104.00%)
What is KemPharm TTM selling, general & administrative expenses?
The current TTM SG&A of KMPH is -$1.13 B
What is the all time high TTM SG&A for KemPharm?
KemPharm all-time high TTM selling, general & administrative expenses is $17.01 M
What is KemPharm TTM SG&A year-on-year change?
Over the past year, KMPH TTM selling, general & administrative expenses has changed by -$1.14 B (-13110.58%)